Successful Treatment of Complicated Gram Negative Sinopulmonary Infections Treated in Infectious Disease (ID) Physician Office Infusion Centers (POICs)

Ramesh V. Nathan, MD- Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Curtis J. FitzSimmons, MD – Plaza Infectious Disease, Kansas City, MO
John S. Adams, MD, -Knoxville Infectious Disease Consultants, PC, Knoxville, TN
Alfred E. Bacon, III, MD- Infectious Disease Associates, PA, Newark, DE
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.